Skip to main content
Clinical Trials/NCT04534400
NCT04534400
Recruiting
Not Applicable

Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic

University Hospital, Strasbourg, France2 sites in 1 country1,000 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
SARS-CoV-2 Infection
Sponsor
University Hospital, Strasbourg, France
Enrollment
1000
Locations
2
Primary Endpoint
Correlation between altered pulmonary volume and ordinal severity scale
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example.

This study aim at assessing the correlation between the amount of radiologic pulmonary alteration and the clinical severity in two clinical situation :

  1. SARS-CoV-2 infections
  2. Postoperative hypoxemic acute respiratory failure
Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
March 1, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patient with insurance covering
  • patient admitted to the participating hospitals for SARS-CoV-2 infection or postoperative acute hypoxemic respiratory failure between 01/01/2019 and 05/11/2020

Exclusion Criteria

  • patient transferred to another hospital than the participating center during the 7 days following the CT scan

Outcomes

Primary Outcomes

Correlation between altered pulmonary volume and ordinal severity scale

Time Frame: 2 days after CT scan

Secondary Outcomes

  • Correlation between altered pulmonary volume and ordinal severity scale(7 days after CT scan)

Study Sites (2)

Loading locations...

Similar Trials